London's Times Examines Test Aimed At Detecting Potential HIV/AIDS Vaccines
Main Category: HIV / AIDSAlso Included In: Immune System / Vaccines
Article Date: 29 Apr 2009 - 5:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The London Times on Monday examined a test that aims to identity the "best potential AIDS vaccine from among other less promising products." According to the Times, early results from the test indicate that it can detect whether a vaccine candidate will stimulate an immune system response and if the response will actively fight HIV/AIDS. The test, developed by Imperial College London and the International AIDS Vaccine Initiative, is known as a viral inhibition assay. The Times reports that the test is being examined in a Phase I HIV/AIDS vaccine trial.
The test uses blood from HIV-negative people who have been injected with a vaccine candidate. Researchers then mix the blood samples with a live virus in a laboratory setting to determine whether the immune system response prevents HIV from replicating. Researchers hope that the test, which is one of several in development, can be used to examine vaccine candidates and select the most promising for large-scale trials. The project is being funded by a grant worth 40 million British pounds, or about $58 million, from the Department for International Development to IAVI.
Jill Gilmour, director of clinical research at IAVI, said that the method of testing mimics infection and immune response in the body and appears to be promising. "The proof of concept is there," she said, adding, "We feel it's pretty reliable. This is measuring something different to the current assays and arguably much more relevant. We believe it can be a key frontline strategy and that it is grounded in sound scientific hypothesis." IAVI President Seth Berkley said, "If we are able to tease out what looks promising and what doesn't, then we have a holy grail. At the moment you get to a point where it's a 'crapshoot' as to what you take forward and what you don't" (Lister, Times, 4/27).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our hiv / aids section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/148046.php>
APA
http://www.medicalnewstoday.com/releases/148046.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



